In mice with TAC-induced cardiomyopathy, LVEF at day 60 was higher with SS31 than with TAC alone, but still lower than in sham-operated mice.
In plain wordsIn mice with heart damage from aortic constriction, SS31 kept heart pumping higher than no treatment, but not as high as in healthy mice.
- Peptide
- Elamipretide (SS-31)
- Outcome
- IncreaseLeft ventricular ejection fraction (LVEF) at day 60
- Study
mousen = 36
transverse aortic constriction (TAC)-induced hypertrophic cardiomyopathy- Comparator
- TAC only
- Outcome group
- Heart function · Cardiovascular
- Studied dose
- 2.0 mg/kg/day · intraperitoneal · from day 28 after TAC induction, euthanasia by day 60As given in this study (mouse).
Source sentences
left ventricular ejection fraction (LVEF) and sarcomere length were significantly lower in group 2 than groups 1 and 3, and significantly lower in group 3 than in group 1
1 context sentence(design, population, supporting numbers)
Adult-male B6 mice (n=36) were equally divided into sham-operated control (group 1), TAC only (group 2) and TAC+SS31 (group) (2.0 mg/kg/day by intra-peritoneal administration from day 28 after TAC induction) and euthanized by day 60.